Galena Biopharma, Inc. (NASDAQ: GALE ) revealed it discontinued NeuVax™ (nelipepimut-S) Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate ...
NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent Data Monitoring Committee (IDMC) has issued a second ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...
An update from Dimerix Limited ( (AU:DXB)) is now available. Dimerix Limited announced the successful completion of the seventh Independent Data Monitoring Committee (IDMC) review of its ACTION3 Phase ...
(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, Thursday ...
Informatica’s latest release brings self-service tuning, LLM integration, and model governance to the forefront of enterprise data management. Informatica is adding new AI-based capabilities to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results